File:40673902210df4898798eo.png

From Wikimedia Commons, the free media repository
Jump to navigation Jump to search

Original file(3,024 × 4,032 pixels, file size: 8.91 MB, MIME type: image/png)

Captions

Captions

Ansuvimab

Summary[edit]

Description
English: May 21, 2018 – A healthy volunteer receives an intravenous infusion of mAb114—an experimental treatment for Ebola virus disease—in a Phase 1 clinical trial held at the NIH Clinical Center in Bethesda, Maryland
Date
Source https://www.flickr.com/photos/niaid/40673902210/
Author NIAID

Licensing[edit]

Public domain This image is in the public domain in the United States because it contains materials that originally came from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health which is an agency of the United States Government.
The NIAID frequently uses commercial images which are not public domain. Email the source site if it is not clearly stated that this specific work is in the public domain.
National Institute of Allergy and Infectious Diseases logo
National Institute of Allergy and Infectious Diseases logo
This image, originally posted to Flickr, was reviewed on 1 March 2024 by the administrator or reviewer Abzeronow, who confirmed that it was available on Flickr under the stated license on that date.

File history

Click on a date/time to view the file as it appeared at that time.

Date/TimeThumbnailDimensionsUserComment
current00:17, 1 March 2024Thumbnail for version as of 00:17, 1 March 20243,024 × 4,032 (8.91 MB)Ozzie10aaaa (talk | contribs)Uploaded a work by NIAID from https://www.flickr.com/photos/niaid/40673902210/ with UploadWizard

There are no pages that use this file.

Metadata